BICX — Biocorrx Cashflow Statement
0.000.00%
Last trade - 00:00
- $12.96m
- $14.46m
- $0.09m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -6.05 | -3.51 | -5.21 | -4.38 | -3.77 |
Depreciation | |||||
Non-Cash Items | 3.2 | 0.899 | 0.905 | 1.73 | 1.18 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.119 | 0.378 | 0.704 | 0.578 | 0.714 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -2.94 | -2.15 | -3.54 | -2.04 | -1.85 |
Capital Expenditures | -0.123 | -0.009 | -0.05 | 0 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.001 | 0 | — | — | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.122 | -0.009 | -0.05 | 0 | — |
Financing Cash Flow Items | 6 | 0 | 2.25 | -0 | -0.001 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.42 | 0.107 | 3.08 | 2.02 | 1.85 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.37 | -2.05 | -0.506 | -0.017 | -0.003 |